Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triheptanoin with Ketogenic Diet in G1D
NCT03301532Phase 2Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Jun 2018
- Primary completion
- Jun 2021
- Modality
- SLNs, Nanostructured Lipid Carriers, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of triheptanoin in Glucose Transporter Type 1 Deficiency Syndrome (Glut1DS), sponsored by UT Southwestern Medical Center. Started Jun 2018; status: completed.
02
Drugs
triheptanoin
03
Conditions
Glucose Transporter Type 1 Deficiency Syndrome (Glut1DS)
Beyond the preview
Go deeper on NCT03301532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03301532.